It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
There's Life in the Old Dog Yet – Ex Parte Injunctions in Switzerland
-
Germany: FCJ’s Digitales Buch – Generalisation and (in)admissible extension?
-
Russia: On a slow boat to patent linkage?
-
Patent case: Judgment no. 550/2018, Spain
-
(Cross-border) jurisdiction, (Indirect) infringement, Enforcement, Equivalents, Infringement, Injunction, Litigation, Netherlands, Pharma
πάντα ῥεῖ
-
Wolters Kluwer partners with AI analytics company, Aistemos.
-
Germany: Anthocyanverbinding, Federal Court of Justice 10 December 2013
-
The Bible and patent law
-
R21/11, European Patent Office (Appeals Court), 15 June 2012
-
Public Prior Use of a Pharmaceutical Preparation (T 2458/09)